Dan Munro has an article in Forbes on new developments for Big Data in Cancer trials driven by Big Pharma and the need to accelerate expensive drug trials.
“Big Pharma Opens New Chapter On Big Data Collaboration”
As Dan points out it will be interesting to see which of three models pans out:
- The Industry centric research model
- The Regulatory-driven model
- The patient-centric model
These are all Big Data solutions that continue to drive the hype in this emerging technology area. There will be bumps in the road as the hype gives way to reality and workable solutions emerge.
Big Data is not taking over the world. It is just searching for its place in the world.
Image courtesy: http://2.healthca.mp/1em8lsy
via WordPress http://2.healthca.mp/1qsV80E
